Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TriLink BioTechnologies, Inc. Awards Brock University ResearchReward

Published: Wednesday, October 24, 2012
Last Updated: Wednesday, October 24, 2012
Bookmark and Share
TriLink announced that it has awarded Dr. Tony Yan of Brock University a ResearchReward for CleanAmp™ PCR reagents, nucleoside triphosphates and oligonucleotides.

These TriLink products are key in Dr. Yan's research on the regulation of nucleic acid hybridization and binding by azobenzene analogues.

"Azobenzene and analogues undergo light-driven geometrical changes and have therefore found applications in systems where such geometrical changes can be taken advantage of. The ResearchRewards from Trilink will allow us to further explore azobenzene derivatives in the spatiotemporal regulations of events involving nucleic acids," stated Dr. Yan, Associate Professor of Chemistry at Brock University.

"We are honored to contribute to Dr. Yan's research and enable the continued development of a promising technology for the oligonucleotide community. Dr. Yan's new twist on azobenzene chemistry could have a positive impact on an array of important applications including aptamer development," commented TriLink CEO, Dr. Richard Hogrefe.

Since its inception in 2002, TriLink's ResearchRewards Program has supported over 30 projects. Areas of research include nucleotide selectivity of error prone RNA viral polymerases, PCR primer design for undergraduate teaching and research, CleanAmp™ Primers for detection of mRNA expression and DNA repair studies of cross-linked DNA.

David Gorin, Assistant Professor of Chemistry at Smith College received a ResearchReward in 2011 to study the use of modified DNA molecules for the selective perturbation of one target compound in a complex mixture, with the goal of using these reagents to study signaling in living systems. "With material supplied by the ResearchRewards program, we have successfully synthesized several modified oligonucleotides, and are currently testing their ability to mediate our desired reactions. Thanks in part to this preliminary work, the Research Corporation recently awarded our lab a Cottrell College Science Award to further support this research," explained Dr. Gorin.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!